The immunotherapy drug market in India includes original biologic manufacturers, emerging biosimilar developers, and a network of specialty pharmacies and distributors — creating a competitive but dynamic landscape. This distribution shapes India Keytruda Market Share among branded drug suppliers and indicates potential shifts as newer alternatives emerge.
While original biologic...
Keytruda (pembrolizumab) — Merck's anti-PD-1 monoclonal antibody that has become the world's highest-revenue pharmaceutical product surpassing Humira — represents the most commercially successful oncology drug in history, with the Keytruda Market reflecting pembrolizumab's extraordinary commercial momentum across an unprecedented portfolio of approved indications.
Pembrolizumab's...
The single most critical factor underpinning the significant growth trajectory of the India Keytruda Market is the dramatic and sustained increase in the incidence of various cancers across the subcontinent, creating an urgent, unmet clinical need.
India's cancer burden is expanding rapidly, fueled by demographic shifts (an aging population) and socio-economic changes that lead to higher rates...